When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BHVN - Axsome Therapeutics: Sliding Share Price And FDA Approvals Highlight Gains
Biohaven Pharmaceutical Holding Company Ltd.
Investment Thesis
Fueled by a string of catalysts, the shares of Axsome Therapeutics, Inc. (AXSM) rose exponentially last year. After achieving the major milestones last year, the stock has declined so far as its net losses keep piling up amid the growing R&D expenditure. However, the company remains well-funded to advance the vital late-stage trials, even though its significant catalysts are unlikely in the near term. Meanwhile, subject to the FDA approval, the NDA filings for AXS-05 and AXS-07 for MDD and migraine, respectively, could uncover a peak sales opportunity of more than